Findings suggest narcolepsy type 1 to be a T-cell mediated autoimmune disease targeting hypocretin-producing neurons.
Category
Research Highlights
-
-
Nakalanga syndrome: Clinical characteristics, potential causes, and its relationship with recently described Nodding syndrome
-
New treatment options for pediatric convulsive status epilepticus after failure of first-line benzodiazepines
-
Zika virus circulation has decreased but there is a possibility of its emergence or re-emergence in all areas with competent mosquito vectors.
-
Levetiracetam and NOACs
-
Second dose of intravenous immunoglobulin for Guillain-Barre syndrome
-
Antiparanodal antibodies in CIDP.
-
Role of right frontal regions in cognition: evidence from intraoperative stimulation in awake people
-
Fluoroquinolone Use Linked to Higher Risk of Peripheral Neuropathy
-
EXTEND study: More evidence on thrombolysis beyond traditional time windows
-
A consensus review on the development of palliative care for patients with chronic and progressive neurological disease.
-
Cognitive functioning and multimodal neuroimaging in narcolepsy type 1
-
Guidelines for single fiber EMG
-
IFCN-endorsed practical guidelines for clinical magnetoencephalography (MEG)
-
Research HighlightsResearch
Neurology Update: Coma & Chronic Disorders of Consciousness & Rare Diseases
July 26, 2019Treating Disorders of Consciousness With Apomorphine: a Clinical Trial Using Multimodal Assessments